Alexandra Picard
Overview
Explore the profile of Alexandra Picard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
42
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rousset P, Nardin C, Maubec E, Heidelberger V, Picard A, Troin L, et al.
Oncologist
. 2024 Jul;
29(10):e1364-e1372.
PMID: 38956747
Background: Currently, treatment options for patients with advanced melanoma who experience failed immunotherapy or targeted therapy are lacking. Recent studies suggest the antitumor activity of combined pembrolizumab and lenvatinib in...
2.
Louisy A, Rochefort J, Plantier F, Kervarrec T, Quilhot P, Godeau S, et al.
Eur J Dermatol
. 2023 Jul;
33(2):109-120.
PMID: 37431113
Background: Plasma cell gingivitis is defined as gingival inflammation comprised of plasma cell infiltrates. This diagnostic criterion is non-specific and underlying mechanisms remain unknown. Objectives: We performed a multidisciplinary clinico-pathological...
3.
de Masson A, Beylot-Barry M, Ram-Wolff C, Mear J, Dalle S, DIncan M, et al.
Lancet
. 2023 Apr;
401(10392):1941-1950.
PMID: 37105210
Background: Advanced-stage cutaneous T-cell lymphomas (CTCLs) are rare, usually refractory, and fatal diseases. Case series have suggested that allogeneic haematopoietic stem cell transplantation (HSCT) might improve the prognosis of advanced-stage...
4.
Razzouk-Cadet M, Picard A, Grangeon-Chapon C, Lacour J, Montaudie H
Clin Nucl Med
. 2019 Jul;
44(10):806-807.
PMID: 31306191
A 49-year-old patient with metastatic melanoma was treated with nivolumab (Opdivo). An early F-FDG PET/CT after 2 cycles showed a progressive metabolic disease. A 4-month optimal follow-up F-FDG PET/CT showed...
5.
Sanchez A, Montaudie H, Bory P, Belgodere X, Passeron T, Lacour J, et al.
JAMA Dermatol
. 2018 Oct;
154(11):1354-1356.
PMID: 30326507
No abstract available.
6.
Montaudie H, Picard A, Panaia-Ferrari P, Boukari F, Passeron T, Sadoul J, et al.
Melanoma Res
. 2018 Jun;
28(4):368-369.
PMID: 29916989
No abstract available.
7.
Doyen J, Picard A, Naghavi A, Thyss A, Passeron T, Lacour J, et al.
JAMA Dermatol
. 2017 Jul;
153(10):1056-1059.
PMID: 28746710
No abstract available.
8.
Picard A, Pedeutour F, Peyrade F, Saudes L, Duranton-Tanneur V, Chamorey E, et al.
JAMA Dermatol
. 2017 Mar;
153(4):291-298.
PMID: 28259104
Importance: Cetuximab was recently proposed for advanced cutaneous squamous cell carcinomas (cSCC); however, its efficacy is inconsistent and identification of predictive biomarkers for response is necessary. Objective: To search for...
9.
Selvick A, Stauss K, Strobush K, Taylor L, Picard A, Doll A, et al.
Dermatitis
. 2016 Sep;
27(5):272-5.
PMID: 27649349
Background: The current method for patch test tray assembly requires hand dispensing a small volume of hapten onto chambers. Because of human error, this technique produces inaccurate and inconsistent results....
10.
Picard A, Tsilika K, Cardot-Leccia N, Passeron T, Lacour J, Bahadoran P
J Am Acad Dermatol
. 2014 Aug;
71(3):e63-4.
PMID: 25128125
No abstract available.